Panelists discuss how maintaining patients on effective single therapies for Crohn’s disease is preferable to switching between different mechanisms of action, while addressing access challenges ...
Patients who achieved HIV virologic suppression tended to be older and were more likely to report continued engagement in HIV care than those with persistent viremia.
Hosted on MSN
Cheaper HIV Prevention Drug Coming
THE INDEPENDENT & AGENCIES | A new long-acting medicine that could make preventing HIV transition might soon be even for poor countries like Uganda thanks to agreements between producers and key ...
For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating-and possibly even curing-the disease a seemingly insurmountable obstacle to achieve.
Cuts proposed by the Trump administration and House Republicans could drive up new HIV cases by more than 200,000 by 2030, one expert projects.
For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even curing—the disease a seemingly insurmountable obstacle to achieve.
Being out of care doesn’t have to be permanent, and many people can restart HIV treatment. The sooner PWH restart treatment, the better, as restarting and staying on HIV treatment can help them reach ...
The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...
Research published in The Lancet HIV earlier this year, experts estimated that, if purchased at scale, the cost of generic lenacapavir could range from USD 35 to USD 46 per person-year. Falling to USD ...
Persistent symptoms after treatment, sometimes called persistent Lyme disease (PLD) or Post Treatment Lyme Disease Syndrome (PTLDS), can include, but are not limited to, fatigue, pain and cognitive ...
Knowing how to leverage these technologies means we can help set the new standard and inform the next evolution of HIV care.
Bay Area nonprofits that provide lifesaving services for people living with HIV/AIDS are fighting to secure sources of income at a time when public health faces devastating cuts to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results